PATIENT NARRATIVES OF THEIR EXPERIENCES AND MOTIVATIONS GOING THROUGH HEPATITIS C (HCV) DRUG TREATMENT

被引:0
|
作者
Gifford, Allen L. [1 ,2 ]
Drainoni, Mari-Lynn [1 ,2 ]
Koppelman, Elisa A. [1 ,2 ]
Clark, Jack A. [1 ,2 ]
机构
[1] Edith Nourse Rogers Mem Vet Adm Hosp, Bedford, MA 01730 USA
[2] Boston Univ, Bedford, MA USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:S326 / S326
页数:1
相关论文
共 50 条
  • [41] Treatment of chronic hepatitis C in patients with HIV/HCV coinfection
    Nicola Coppola
    Salvatore Martini
    Mariantonietta Pisaturo
    Caterina Sagnelli
    Pietro Filippini
    Evangelista Sagnelli
    World Journal of Virology, 2015, 4 (01) : 1 - 12
  • [42] HEPATITIS C - REAL WORLD EFFECTIVENESS OF HCV TREATMENT IN POLAND
    Plisko, R.
    Wladysiuk, M.
    Miazga, P.
    Bebrysz, M.
    VALUE IN HEALTH, 2016, 19 (07) : A408 - A408
  • [43] Treatment of Hepatitis C Virus (HCV) Genotype 1 Disease
    Kimberly A. Forde
    Debika Bhattacharya
    Current Treatment Options in Infectious Diseases, 2017, 9 (2) : 262 - 276
  • [44] The Egyptian hepatitis C programme: A model of HCV treatment intervention?
    Lemoine, M.
    Cooke, G. S.
    JOURNAL OF HEPATOLOGY, 2018, 68 (04) : 638 - 639
  • [45] Spectroscopic study to verify the anti-hepatitis C virus (HCV) treatment through a delivery system of the sofosbuvir drug on chitosan and pycnogenol nanoparticles surface
    El-Shafai, Nagi M.
    Nada, Ahmed I.
    Farrag, Mahmoud A.
    Alatawi, Kahdr
    Alalawy, Adel I.
    Al-Qahtani, Salhah D.
    El-Mehasseb, Ibrahim M.
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2023, 302
  • [46] HIV and hepatitis B and hepatitis C coinfection: Treatment and practical experiences
    Breitschwerdt S.
    Boesecke C.
    MMW - Fortschritte der Medizin, 2024, 166 (Suppl 2) : 38 - 43
  • [47] Real-World Evaluation of the Economic Impact of Duration of Drug Therapy in the Treatment of Hepatitis C Virus (HCV)
    McCombs, Jeffrey S.
    Shin, Janet
    Hines, Patricia
    Saab, Sammy
    Yuan, Yong
    GASTROENTEROLOGY, 2011, 140 (05) : S936 - S936
  • [48] NOTIFICATION OF HEPATITIS C SEROSTATUS IMPROVES THE ADHERENCE OF HCV SEROPOSITIVE DRUG USERS RECEIVING METHADONE MAINTENANCE TREATMENT
    Zhang, Huaihui
    Wang, Zhenhua
    Li, Yongchao
    Han, Hesong
    ANNALS OF BEHAVIORAL MEDICINE, 2013, 45 : S308 - S308
  • [49] Outpatient drug treatment program directors' hepatitis C-related beliefs and their relationship to the provision of HCV services
    Astone, JM
    Strauss, SM
    Hagan, H
    Jarlais, DCD
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2004, 30 (04): : 783 - 797
  • [50] In vitro and in vivo evaluation of HCV polymerase inhibitors as potential drug candidates for treatment of chronic hepatitis C infection
    Ilan, E
    Zauberman, A
    Aviel, S
    Nussbaum, O
    Arazi, E
    Ben-Moshe, O
    Slama, D
    Tzionas, I
    Shoshany, Y
    Lee, SW
    Han, JJ
    Park, SJ
    Lee, GH
    Park, EY
    Shin, JC
    Suh, JW
    Kim, JW
    Dagan, S
    ANTIVIRAL RESEARCH, 2004, 62 (02) : A83 - A83